Pierre Bohn

Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia with 18fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study

Pierre Véra, Pierre Bohn, Agathe Edet‐Sanson et al. · Radiotherapy and Oncology · 2010 · 127 citations

Medicine, Nuclear Medicine, Oncology +16

Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a “Bio-Oxidizable” Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation

Ludovic Peauger, Rabah Azzouz, Vincent Gembus et al. · Journal of Medicinal Chemistry · 2017 · 93 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by ¹⁸F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)

Pierre Véra, S. Thureau, Philippe Chaumet‐Riffaud et al. · Journal of Nuclear Medicine · 2017 · 83 citations · Full text

Medicine, Nuclear Medicine, Radiation Oncology +17

Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC)

Agathe Edet‐Sanson, Bernard Dubray, Kaya Doyeux et al. · Radiotherapy and Oncology · 2011 · 61 citations

Medicine, Nuclear Medicine, Oncology +17

Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]

Pierre Véra, Sorina‐Dana Mihailescu, Justine Lequesne et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 51 citations

Medicine, Nuclear Medicine, Oncology +17